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Background: Peripheral arterial disease (PAD) is a significant problem in the U.S., and smoking is a known risk factor for PAD. Little is known 
regarding the impact of smoking status and peripheral vascular intervention (PVI) outcomes. The purpose of this study was to evaluate the impact of 
smoking status on peri-procedural characteristics, and in-hospital outcomes of patients undergoing PVI procedures.
Methods: Between 01/2004 through 12/2010, data was recorded in a in a regional, contemporary, multi-center, multi-disciplinary registry on a 
total of 18,386 PVI’s. Groups were classified as non-smokers, former smokers (those who quit at least one month prior to intervention), and current 
smokers.
Results: Patient demographics, co-morbitities, presenting symptoms, arterial bed treated and PVI outcome based on smoking status are shown 
(see table). Multivariate analysis, however, revealed that smoking status was not independently associated with the need for transfusion or 
amputation.
Conclusions: In this study of patients presenting for PVI, active smokers were younger, had fewer other co-morbidities, and were more likely to 
have claudication and undergo aorto-iliac intervention. Active smoking was not associated with more peri-procedural complications or decreased 
technical or procedural success.
Peripheral Vascular Intervention Demographics, Symptoms, and Outcomes Based on Smoking Status
Current Smokers (n= 6095) Former Smokers (n= 8700) Non-smokers (n= 3591) p-value
Age (SD) 62.3 (10.1) 70.1 (10.2) 73.7 (11.9) <0.0001
Female 2253 (37%) 3231 (37%) 2171 (60%) <0.0001
Diabetes 2261 (37%) 4378 (50%) 2104 (59%) <0.0001
Claudication 3784 (62%) 5228 (60%) 1647 (46%) <0.0001
Limb ischemia 2191 (36%) 3326 (38%) 1864 (52%) <0.0001
Aorto-iliac 2611 (43%) 2726 (31%) 486 (14%) <0.0001
Below-the-knee 1001 (16%) 2131 (25%) 1632 (46%) <0.0001
MACE (Death, MI, CVA/TIA) 59 (0.9%) 115 (1.3%) 42 (1.2%) 0.10
Transfusion 347 (6%) 645 (7%) 300 (8%) 0.90
